Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Piedmont Research Center is a contract research organization (CRO) that specializes in preclinical oncology and immunology services. Based in Morrisville, North Carolina, the center provides a comprehensive range of in vivo and in vitro services, including efficacy testing, pharmacology, and molecular biology for drug discovery. It is widely recognized for its extensive collection of human tumor xenograft models and syngeneic models used to evaluate novel cancer therapies. Originally a division of Genzyme Corporation, the company was acquired by Charles River Laboratories in 2009 to enhance their global discovery services portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Piedmont Research Center.